Emory University’s Immunomedics Inc IMMU Stock Holding History

Emory University’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-123,101	Closed	-$1.76M	–	51
2018 Q4	$1.76M	Sell	123,101 -2,151	-2%	-$42.7K	1.38%	31
2018 Q3	$2.61M	Buy	+125,252	New	+$2.97M	1.71%	21

Other funds holding IMMU

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Emory University's IMMU Position: Q1 2019 in Review

Emory University sold out of Immunomedics Inc (IMMU) in Q1 2019, closing a stake of 123,101 shares — an estimated $1.76M sold.

Emory University first reported a position in IMMU in Q3 2018 and held it in 2 quarters. The position peaked at $2.61M in Q3 2018. 204 funds tracked by Wall St. Rank hold IMMU as of Q1 2019.

Emory University reported no remaining Immunomedics Inc position as of Q1 2019 after selling out during the quarter.
Emory University sold 123,101 Immunomedics Inc shares in Q1 2019, an estimated $1.76M.
Emory University first reported a position in Immunomedics Inc in Q3 2018 and held it in 2 quarters.
Emory University's Immunomedics Inc position peaked at $2.61M in Q3 2018.
204 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2019.

Based on Emory University's 13F filing for Q1 2019, filed 9 May 2019.